Media

Patrizia Paterlini Interviewed by Newsmax Saturday Agenda

Rarecells CEO Prof. Patrizia Paterlini Discusses Detecting Cancer Before It Appears on Imaging on Newsmax’s Saturday Agenda New York, NY — September 26, 2026 Prof. Patrizia Paterlini, MD, PhD, founder and CEO of Rarecells, appeared on Newsmax’s Saturday Agenda on Saturday, September 26, 2026, to discuss how detecting tumor cells in the blood could allow […]

Patrizia Paterlini Interviewed by Newsmax Saturday Agenda Read More »

Oncolife Highlights Rarecells in Salute Europa Interview with Founder Dr. Patrizia Paterlini, MD, PhD

Hunting the “Invisible Enemy”: Liquid Biopsy and the Stage Zero Revolution Detecting cancer years before it becomes visible through traditional diagnostic tests. This is the wager of Prof. Patrizia Paterlini-Bréchot and the technology that isolates “sentinels” in the bloodstream. By Sergio Gentili (Translated from Italian: https://www.oncolife.it/news/biopsia-liquida/) December 22, 2025 For decades, oncology has operated according

Oncolife Highlights Rarecells in Salute Europa Interview with Founder Dr. Patrizia Paterlini, MD, PhD Read More »

Vanity Fair Italy Interviews Rarecells Founder Dr. Patrizia Paterlini

Oncologist Patrizia Paterlini: «I look for tumor cells before the tumor becomes visible, which is why I patented a test that looks for tumor cells in the blood in the very early stages of development»   “I chose research because, as an oncologist, I saw too many patients die—I felt powerless,” says the researcher who

Vanity Fair Italy Interviews Rarecells Founder Dr. Patrizia Paterlini Read More »

Scroll to Top

You're one click away from your download !

Please enter the requested information below and click SEND

You're one click away from your download !

Please enter the requested information below and click SEND

You're one click away from your download !

Please enter the requested information below and click SEND